Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS) -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (59)	2/7/2000 6:46:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 1833

>> A daytrading induced pop into the $2's today would not have broken my heart << IMO, a nice pop could come from many different directions. I don't think anyone knows about the stock. In an attempt to navigate Yahoo yesterday and on advice of someone who posted to the KDUS thread there, I tried to search for "KDUS". It only turned up two posts. A few months ago, potential royalties were valued at $0. Today, we are rolling in premium for "good pipeline", and the OSIP-Solvay and OSIP-KDUS projects appear to be hopping. Repeat before going to bed at night... "adenosine receptors are hot." Price:book is still under 2, and there's always this part of the OSIP 10-K...... "Several assets were retained by Cadus, including (a) monies in escrow in connection with the judgment of SIBIA Neurosciences, Inc. against Cadus, (b) cash and accounts receivable, (c) Cadus' Living Chip Technology, (d) Cadus' Functional Genomics Program, and (e) Cadus' Research Collaboration and License Agreement with SmithKline Beecham Corporation." So.... lots of potential for pop and very safe on downside, IMO. Dave's focus is the PTO and the escrow money, and -- with this float -- positive news there would send us flying.